151 related articles for article (PubMed ID: 7906979)
1. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
[No Abstract] [Full Text] [Related]
2. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
Untch M; Sevin BU
Contrib Gynecol Obstet; 1994; 19():145-55. PubMed ID: 7995046
[No Abstract] [Full Text] [Related]
4. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
5. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
Köchli OR; Sevin BU; Schär G; Haller U
Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
[TBL] [Abstract][Full Text] [Related]
6. Review of data on gynecologic cancer cell lines: potential applications of ATP-cell viability assays.
Nguyen HN; Sevin BU; Perras JP; Averette HE
Contrib Gynecol Obstet; 1994; 19():132-44. PubMed ID: 7995045
[No Abstract] [Full Text] [Related]
7. ATP-cell viability assay methodology in both fresh gynecologic tumors and cell lines.
Köchli OR; Perras JP; Sevin BU
Contrib Gynecol Obstet; 1994; 19():108-21. PubMed ID: 7995042
[No Abstract] [Full Text] [Related]
8. In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
Koechli OR; Schaer GN; Sevin BU; Perras JP; Schenk V; Rodriguez M; Untch M; Steren A; Haller U
Anticancer Drugs; 1995 Feb; 6(1):94-100. PubMed ID: 7756689
[TBL] [Abstract][Full Text] [Related]
9. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
Sevin BU; Perras JP
Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
Ojima I; Geng X; Lin S; Pera P; Bernacki RJ
Bioorg Med Chem Lett; 2002 Feb; 12(3):349-52. PubMed ID: 11814794
[TBL] [Abstract][Full Text] [Related]
11. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
12. New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals.
Ishiyama T; Iimura S; Ohsuki S; Uoto K; Terasawa H; Soga T
Bioorg Med Chem Lett; 2002 Apr; 12(7):1083-6. PubMed ID: 11909723
[TBL] [Abstract][Full Text] [Related]
13. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
Liu S; Qian X; Peng Z; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
[TBL] [Abstract][Full Text] [Related]
14. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
15. [Chemosensitivity test of breast cancer].
Oura S; Tanino H; Naito Y
Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
[No Abstract] [Full Text] [Related]
16. Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) cultures.
Griffon-Etienne G; Merlin JL; Marchal C
Anticancer Drugs; 1996 Aug; 7(6):660-70. PubMed ID: 8913435
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
Pendri A; Conover CD; Greenwald RB
Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
[TBL] [Abstract][Full Text] [Related]
18. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
Nogaki M; Ichihashi H
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
[TBL] [Abstract][Full Text] [Related]
19. New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 3.
Takeda Y; Yoshino T; Uoto K; Chiba J; Ishiyama T; Iwahana M; Jimbo T; Tanaka N; Terasawa H; Soga T
Bioorg Med Chem Lett; 2003 Jan; 13(2):185-90. PubMed ID: 12482420
[TBL] [Abstract][Full Text] [Related]
20. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]